FSD Pharma Inc(HUGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HUGE FSD Pharma Inc

Pre-Market Trading 12-23 08:27:38 EST

5.84

+0.00

0.00%

High5.84	Low5.84	Vol0.00
Open5.84	D1 Closing5.84	Amplitude0.00%
Mkt Cap382.83M	Tradable Cap240.51M	Total Shares65.51M
T/O2.13M	T/O Rate0.00%	Tradable Shares41.16M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"HUGE","market":"US","secType":"STK","nameCN":"FSD Pharma Inc","latestPrice":5.8435,"timestamp":1723665600000,"preClose":5.8435,"halted":8,"volume":0,"delay":0,"floatShares":41158600,"shares":65513746,"eps":-0.247679,"marketStatus":"Pre-Market Trading","change":0,"latestTime":"12-23 08:27:38 EST","open":5.8435,"high":5.8435,"low":5.8435,"amount":2130606.1116234,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.247679,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1734964200000},"marketStatusCode":1,"symbolChange":{"newSymbol":"QNTM","executeDate":"2024-08-15"},"adr":0,"exchange":"NASDAQ","adjPreClose":5.8435,"volumeRatio":0},"requestUrl":"/m/hq/s/HUGE/tweets","defaultTab":"tweets","newsList":[{"id":"2459644658","title":"FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol \"QNTM\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2459644658","media":"Newsfile","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459644658?lang=en_us&edition=fundamental","pubTime":"2024-08-15 18:00","pubTimestamp":1723716000,"startTime":"0","endTime":"0","summary":"Toronto, Ontario-- - Quantum BioPharma Ltd.   , formerly FSD Pharma Inc., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that, further to its press release dated August 9, 2024 , effective today the Name Change  and the Consolidation  has been completed. The Company's expects that its class B subordinate voting shares  will commence trading under the new ticker symbol \"QNTM\" at the market open today on The Nasdaq Capital Market and the Canadian Securities Exchange, on a 65:1 post-Consolidation basis.Upon Company's new CUSIP and ISIN for the Class B Subordinate Voting Shares are 74764Y205 and CA74764Y2050, respectively.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fsd-pharma-completes-name-change-100000019.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fsd-pharma-completes-name-change-100000019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol \"QNTM\"","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUGE","BK4007","BK4555","BK4099","BK4551","QNTM"],"gpt_icon":1},{"id":"2458978529","title":"FSD Pharma Announces Share Consolidation and Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2458978529","media":"Newsfile","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458978529?lang=en_us&edition=fundamental","pubTime":"2024-08-10 08:00","pubTimestamp":1723248000,"startTime":"0","endTime":"0","summary":"Toronto, Ontario-- - FSD Pharma Inc.    , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce the proposed consolidation of its issued and outstanding class A multiple voting shares  and class B subordinate voting shares  of the Company on the basis of one  post-consolidation Class A Multiple Voting Share and Class B Subordinate Voting Share for every sixty-five  pre-consolidation Class A Multiple Voting Shares and Class B Subordinate Voting Shares . This ratio is within the ratio range approved by the Company's stockholders at its annual general and special meeting held on July 22, 2024.The Company will also change its name to \"Quantum BioPharma Ltd.\" , and, subject to approval by The Nasdaq Capital Market , the Class B Subordinate Voting Shares will commence trading on the Canadian Securities Exchange  and Nasdaq under the new trading symbol \"QNTM\" on both the CSE and Nasdaq at the market open on August 15, ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/G.PQqlowVOBZfuUeiiBG.Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/a01247ef7e82c4df937117dd75e5e3c2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/G.PQqlowVOBZfuUeiiBG.Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/a01247ef7e82c4df937117dd75e5e3c2"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fsd-pharma-announces-share-consolidation-000000278.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fsd-pharma-announces-share-consolidation-000000278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4555","HUGE","BK4099","BK4551"],"gpt_icon":1},{"id":"2458333516","title":"US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2458333516","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458333516?lang=en_us&edition=fundamental","pubTime":"2024-08-10 00:29","pubTimestamp":1723220949,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/08/40289992/us-stocks-edge-lower-echostar-shares-tumble-after-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","SATS","NQmain","BK4157","MNQmain","BK4089","HYZN","QID","BK4149","BK4141","BK4100","VEV","MMAT","HUGE","ANTX","PSQ","QLD","BK4007","TQQQ","ITI",".IXIC"],"gpt_icon":1},{"id":"2458569775","title":"FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2458569775","media":"ACCESSWIRE","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458569775?lang=en_us&edition=fundamental","pubTime":"2024-08-09 19:30","pubTimestamp":1723203000,"startTime":"0","endTime":"0","summary":"TORONTO, ON / ACCESSWIRE / August 9, 2024 / FSD Pharma Inc.  , provides an update on its investment in Celly Nutrition Corp. , a privately held Canadian company launching an innovative beverage product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption.On August 9, 2024, Celly Nutrition which is backed by a world-class pharmaceutical research & development team at FSD Pharma, operated by CEO John Duffy, formerly of Coca-Cola, and co-chaired by Gerry David the former CEO of Celsius Holdings  proudly announces the imminent launch of its revolutionary, great tasting and scientifically backed product, unbuzzd. This milestone marks the beginning of a new era in recovery solutions with the introduction of convenient, grab-and-go stick packs. Designed by scientists for use anywhere, unbuzzd offers consumers an innovative approach to helping accelerate alcohol metabolism, restore mental clarity, and prepare for what's next.Celly Nutrition plans to add","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Mq65tsDaWvl8MSSLCVTGdg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9b4b3ebb2c8010e8a90223be72c166d7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Mq65tsDaWvl8MSSLCVTGdg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9b4b3ebb2c8010e8a90223be72c166d7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fsd-pharma-provides-investment-celly-113000793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4099","BK4120","BK4007","BK4551","TM","BK4177","BK4555","HUGE","BK4585","BK4588","03160","TISI","LU2065731478.USD"],"gpt_icon":1},{"id":"2456574132","title":"July was a HUGE month for CBA shares. Here's why","url":"https://stock-news.laohu8.com/highlight/detail?id=2456574132","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2456574132?lang=en_us&edition=fundamental","pubTime":"2024-08-03 04:00","pubTimestamp":1722628800,"startTime":"0","endTime":"0","summary":"While August is kicking off with a bit of a whimper, July was a huge month for Commonwealth Bank of Australia(ASX: CBA) shares. Shares in the S&P/ASX 200 Index(ASX: XJO)bank stock closed on 28 June tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/08/03/july-was-a-huge-month-for-cba-shares-heres-why/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BHP.AU","BK7135","BK7507","HUGE","CBA.AU","XKO.AU","BK4007","XJO.AU","CBA","BK7095","BK7511","XAO.AU"],"gpt_icon":0},{"id":"2454879758","title":"24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2454879758","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454879758?lang=en_us&edition=fundamental","pubTime":"2024-07-25 21:20","pubTimestamp":1721913600,"startTime":"0","endTime":"0","summary":"To read the full article on 247marketnews.com, please click here.The report discusses FSD Pharma's revolutionary rapid alcohol detoxification drink, unbuzzd, which helps to rapidly restore mental alertness post-alcohol consumption. FSD Pharma teamed up with the top industry vets to form Celly Nutrition, led by an all-star team that includes Gerry David, who headed one of the fastest growing energy drink brands and legendary Shark Tank investor, Kevin Harrington, who helped develop the Celsius Influencer marketing program.24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.24/7 MARKET NEWS, INC DisclaimerPlease go to 24/7 Market News disclosure or HUGE disclosure for disclaimer information.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BIr1myOFFmW6.Jljc0GJKw--~B/aD0yOTc7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/a23874f5d422c3e0ff71ec70ef89ba11","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BIr1myOFFmW6.Jljc0GJKw--~B/aD0yOTc7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/a23874f5d422c3e0ff71ec70ef89ba11"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/24-7-market-news-publishes-132000849.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/24-7-market-news-publishes-132000849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUGE","BK4007"],"gpt_icon":0},{"id":"2453078984","title":"PORSCHE  CFO: ANY CASH INVESTMENT IN VARTA AG WILL BE VERY LIMITED; WILL NOT CREATE A HUGE BURDEN FOR PORSCHE","url":"https://stock-news.laohu8.com/highlight/detail?id=2453078984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453078984?lang=en_us&edition=fundamental","pubTime":"2024-07-24 16:30","pubTimestamp":1721809825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240724:nL8N3JG0N8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4541","BK4588","BK4182","BK4211","LU0444973449.USD","FOR","BK4097","BK4210","LU0476273544.USD","BK4023","LU0444971666.USD","LU2357125470.USD","LU2506951792.HKD","BK4007","LU2249611893.SGD","CASH","LU0823414478.USD","LU2294711713.HKD","VERY","LU1815336760.USD","ANY","LU0823414551.USD","BK4162","BK4024","LU1642822529.SGD","AG","BK4585","LU0957808578.USD","BE","HUGE"],"gpt_icon":0},{"id":"2453221064","title":"FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2453221064","media":"Newsfile","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453221064?lang=en_us&edition=fundamental","pubTime":"2024-07-24 03:34","pubTimestamp":1721763240,"startTime":"0","endTime":"0","summary":"Toronto, Ontario-- - FSD Pharma Inc.    , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to announce today the results of its annual general and special meeting of shareholders, held on Monday, July 22, 2024 in person at 801-1 Adelaide Street Eat, Toronto, ON M5C 2V9 .There were shareholders represented in person or by proxy at the AGSM holding 72 class A multiple voting shares  and 15,960,879 class B subordinate voting shares , representing 100% and 35.45% of the votes attached to the Class A Multiple Voting Shares and Class B Subordinate Voting Shares, respectively, with each Class A Multiple Voting Share entitling the holders thereof to 276,660 votes on all matters, for each Class A Multiple Voting Share held.Each nominee listed in the Company's management information circular dated June 10, 2024, was elected as a director of the Company. Each director will serve until the next annual meeting of shareholders or unt","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/EVmBQR2QLFGNDHTwxEr5Tw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/6a65f8f6ad7830b9c83fd2b4a99c94bc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/EVmBQR2QLFGNDHTwxEr5Tw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/6a65f8f6ad7830b9c83fd2b4a99c94bc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fsd-pharma-inc-announces-results-193400636.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fsd-pharma-inc-announces-results-193400636.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4555","HUGE","BK4099","BK4551"],"gpt_icon":1},{"id":"2453555450","title":"24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2453555450","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453555450?lang=en_us&edition=fundamental","pubTime":"2024-07-23 22:29","pubTimestamp":1721744940,"startTime":"0","endTime":"0","summary":"To read the full article on 247marketnews.com, please click here. The report discusses FSD Pharma's revolutionary rapid alcohol detoxification drink, UNBUZZD, which helps to rapidly restore mental alertness post-alcohol consumption. FSD Pharma teamed up with the top industry vets to form Celly Nutrition, led by an all-star team that includes Gerry David, who headed one of the fastest growing energy drink brands and legendary Shark Tank investor, Kevn Harrington, who helped develop the Celsius Influencer marketing program.24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.24/7 MARKET NEWS, INC DisclaimerPlease go to 24/7 Market News disclosure or HUGE disclosure for disclaimer information.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Ii7bCqVKIYONMRjs9pqFgw--~B/aD0yMDA7dz0yMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/ca58bd26a9f0afd4700bbb72cc291926","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Ii7bCqVKIYONMRjs9pqFgw--~B/aD0yMDA7dz0yMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/ca58bd26a9f0afd4700bbb72cc291926"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/24-7-market-news-publishes-142900834.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/24-7-market-news-publishes-142900834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUGE","BK4007"],"gpt_icon":0},{"id":"2448440370","title":"FSD Pharma Files Amended and Restated Material Change Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2448440370","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2448440370?lang=en_us&edition=fundamental","pubTime":"2024-07-04 20:00","pubTimestamp":1720094400,"startTime":"0","endTime":"0","summary":"Toronto, Ontario-- - FSD Pharma Inc.    , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced today that it has filed an amended and restated its material change report dated December 7, 2023 , in order to amend the disclosure in Section 5.1 of the Original MCR.The amended and restated material change report  is being filed to provide additional disclosure with respect of the private placement offering of Class A Multiple Voting Shares of the Company  that closed on December 5, 2023 . The Amended and Restated MCR can be found on the Company's SEDAR+ profile at www.sedarplus.ca.A summary of the changes made in the Amended and Restated MCR are described below.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KEs8M_2Sr3MpZL9ZuommJw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/2442bc1e672be7a5651d2298955e4aeb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KEs8M_2Sr3MpZL9ZuommJw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/2442bc1e672be7a5651d2298955e4aeb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fsd-pharma-files-amended-restated-120000033.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fsd-pharma-files-amended-restated-120000033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4555","BK4007","HUGE","BK4551","BK4099","LCID"],"gpt_icon":0},{"id":"2447003653","title":"FSD Pharma provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2447003653","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447003653?lang=en_us&edition=fundamental","pubTime":"2024-06-29 05:00","pubTimestamp":1719608400,"startTime":"0","endTime":"0","summary":"TORONTO, ON / ACCESSWIRE / June 28, 2024 / FSD Pharma Inc.  , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.Corporate UpdateFSD Pharma has retained the services of Totaligent, Inc.  who will play a key role in assisting the Company to enhance its market awareness and foster productive, continuing dialogues with shareholders and other market participants. Totalaligent has over 25 years of experience in market awareness campaigns and has assembled a database of 32 million active investors and reaches its investment community by way of email, SMS, social media, push notification, pay-per-click , search, and digital and print media. Management has engaged Totalaligent to conduct Promotional Activity  following a thorough review of capital on hand.In addition, the Company issued 650,000 Class B Subordinate Voting shares in the capital of the Corporation  to arm's length creditors ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Mq65tsDaWvl8MSSLCVTGdg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9b4b3ebb2c8010e8a90223be72c166d7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Mq65tsDaWvl8MSSLCVTGdg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9b4b3ebb2c8010e8a90223be72c166d7"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fsd-pharma-provides-corporate-210000166.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUGE"],"gpt_icon":0},{"id":"2447658237","title":"Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2447658237","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447658237?lang=en_us&edition=fundamental","pubTime":"2024-06-29 04:59","pubTimestamp":1719608393,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["US2Y.BOND","US912797HE00.BOND","BK4561","MT","US7Y.BOND","US912797GL51.BOND","US5Y.BOND","US912797GW17.BOND","US10Y.BOND","US3Y.BOND","EML","BK4006","HUGE","US12M.BOND","US30Y.BOND","BK4161","US912797GK78.BOND","US6M.BOND","US912797GB79.BOND","BK4007"],"gpt_icon":0},{"id":"2447637392","title":"Sector Update: Health Care Stocks Decline in Late Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2447637392","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447637392?lang=en_us&edition=fundamental","pubTime":"2024-06-29 03:58","pubTimestamp":1719604726,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["LU0098860793.USD","LU1668664300.SGD","QQQ","LU2210149790.SGD","ALMS","CGON","BK4585","PSQ","LU0106831901.USD","LU0320765646.SGD","BK4135","BK4196","LU2095319765.USD","ACCD","LU1074936037.SGD","LU1989772840.SGD","XLV","FDN","IBB","NDAQ","BK4112","BK4534","BK4588","IE00BKVL7J92.USD","LU0971096721.USD","HUGE","SQQQ","LU2210150020.SGD","NQmain","LU1989772923.USD","QLD","BK4007","LU1162221912.USD",".IXIC","LU1363072403.SGD","BK4127","MNQmain","IE00BZ1G4Q59.USD","NYSE","BK4550","QID","BK4581","TQQQ","BK4504","CG","BK4139"],"gpt_icon":0},{"id":"2447637319","title":"Sector Update: Health Care Stocks Decline in Late Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2447637319","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447637319?lang=en_us&edition=fundamental","pubTime":"2024-06-29 03:58","pubTimestamp":1719604726,"startTime":"0","endTime":"0","summary":"Health care stocks were retreating late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund  shedding 0.4%.The iShares Biotechnology ETF  fell 1%.In corporate news, Accolade  shares plunged 44% after Morgan Stanley halved the company's price target to $6 from $12 while keeping its equal-weight rating following its Q1 results and guidance. Truist also cut its price objective to $9 from $14.FSD Pharma's  former board chairman and chief executive owes more than $2.2 million, plus interest, to the company, after a federal court confirmed a November 2022 arbitration award. FSD Pharma shares were falling 4.5%.Alumis  shares fell 20% in their trading debut on Nasdaq Friday after the clinical-stage biopharmaceutical company priced its initial public offering of about 13.1 million shares at $16 per share.CG Oncology's  cretostimogene immunotherapy to treat bladder cancer is expected to achieve over $4 billion in non-risk adjusted sales by 2037","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0106831901.USD","IE00BZ1G4Q59.USD","ACCD","IBB","BK4585","LU0971096721.USD","LU1668664300.SGD","LU1989772923.USD","LU1074936037.SGD","BK4588","LU1363072403.SGD","LU1162221912.USD","BK4196","LU0098860793.USD","HUGE","XLV","BK4581","LU1989772840.SGD","BK4139","ALMS","CGON","BK4127","LU0320765646.SGD","IE00BKVL7J92.USD","BK4007","BK4534","BK4504"],"gpt_icon":0},{"id":"2447634861","title":"Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2447634861","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447634861?lang=en_us&edition=fundamental","pubTime":"2024-06-29 03:01","pubTimestamp":1719601312,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["EML","MT","US7Y.BOND","US30Y.BOND","US12M.BOND","US2Y.BOND","US3Y.BOND","HUGE","US912797GB79.BOND","US912797GK78.BOND","US6M.BOND","BK4161","US912797GL51.BOND","BK4561","US5Y.BOND","US10Y.BOND","BK4006","BK4007","US912797GW17.BOND","US912797HE00.BOND"],"gpt_icon":0},{"id":"2447631356","title":"FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2447631356","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447631356?lang=en_us&edition=fundamental","pubTime":"2024-06-29 02:40","pubTimestamp":1719600015,"startTime":"0","endTime":"0","summary":"FSD Pharma's  former board chairman and chief executive owes more than $2.2 million, plus interest, to the company, after a federal court confirmed a November 2022 arbitration award.Former FSD Pharma CEO Raza Bokhari was fired in July 2021, following an internal dispute over a prospective acquisition. Bokhari challenged the termination in US federal court in Pennsylvania as well as arbitration in Ontario, where FSD Pharma is based.The damages award, confirmed by the US District Court for the Eastern District of Pennsylvania, includes nearly $570,000 in proceeds from FSD Pharma class B stock sale, almost $329,000 paid to former US Senator Rick Santorum using company funds, and reimbursing $70,000 he paid for four personal flights.FSD Pharma shares were nearly 5% higher in recent trading Friday.Price: 0.18, Change: +0.01, Percent Change: +4.71","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["US2Y.BOND","US12M.BOND","US7Y.BOND","US912797GL51.BOND","US10Y.BOND","US3Y.BOND","US912797HE00.BOND","US912797GK78.BOND","US6M.BOND","US912797GB79.BOND","HUGE","US30Y.BOND","US912797GW17.BOND","US5Y.BOND","BK4007"],"gpt_icon":0},{"id":"2447313966","title":"FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2447313966","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447313966?lang=en_us&edition=fundamental","pubTime":"2024-06-29 02:40","pubTimestamp":1719600015,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4161","US912797HE00.BOND","US12M.BOND","US2Y.BOND","EML","US5Y.BOND","HUGE","US3Y.BOND","US912797GW17.BOND","US30Y.BOND","US912797GL51.BOND","US10Y.BOND","US912797GB79.BOND","US912797GK78.BOND","US6M.BOND","US7Y.BOND","BK4007"],"gpt_icon":0},{"id":"2446450679","title":"FSD Pharma Inc - Wins Final Judgment to Confirm Arbitration Award of $3.06 Mln Plus Interest Entered Against Raza Bokhari","url":"https://stock-news.laohu8.com/highlight/detail?id=2446450679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446450679?lang=en_us&edition=fundamental","pubTime":"2024-06-28 20:00","pubTimestamp":1719576007,"startTime":"0","endTime":"0","summary":"FSD Pharma Inc - Wins Final Judgment to Confirm Arbitration Award of $3.06 Mln Plus Interest Entered Against Raza Bokhari","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240628:nFWN3IQ133:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HUGE"],"gpt_icon":0},{"id":"2446067535","title":"FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2446067535","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446067535?lang=en_us&edition=fundamental","pubTime":"2024-06-27 19:30","pubTimestamp":1719487800,"startTime":"0","endTime":"0","summary":"TORONTO, ON / ACCESSWIRE / June 27, 2024 / FSD Pharma Inc.  , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces that it has received approval by the human ethics review committee  in Australia for its trial entitled \"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants.\". Lucid-21-302 is a first-in-class, non-immunomodulatory, neuroprotective compound with a unique mechanism of action for the treatment of multiple sclerosis . It is a patented New Chemical Entity that has been shown in preclinical models to prevent demyelination, a known cause of MS and other neurogenerative diseases characterized by damage to the myelin sheath surrounding nerve fibers in the central nervous system.In addition, the company issued 400,000 Class B Subordinate Votin","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Mq65tsDaWvl8MSSLCVTGdg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9b4b3ebb2c8010e8a90223be72c166d7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Mq65tsDaWvl8MSSLCVTGdg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9b4b3ebb2c8010e8a90223be72c166d7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fsd-pharma-receives-ethics-committee-113000042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0971096721.USD","LU0320765646.SGD","BK4588","LU1989772923.USD","BK4555","LU1668664300.SGD","LU1363072403.SGD","BK4127","LCID","BK4099","BK4585","LU1074936037.SGD","IE00BZ1G4Q59.USD","BK4551","IE00BKVL7J92.USD","LU0098860793.USD","LU0106831901.USD","LU1989772840.SGD","HUGE","BK4007","BK4534","BK4581","BK4504","LU1162221912.USD"],"gpt_icon":0},{"id":"2445326800","title":"Game-Changing Altcoins Ready to Make a HUGE Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2445326800","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2445326800?lang=en_us&edition=fundamental","pubTime":"2024-06-23 17:44","pubTimestamp":1719135894,"startTime":"0","endTime":"0","summary":"In the ever-evolving world of cryptocurrencies, Ripple, Filecoin, and Dai stand out as game changers, ready to make significant impacts, a sentiment echoed by the excitement around PawFury. R","market":"us","thumbnail":"https://academy-public.coinmarketcap.com/srd-optimized-uploads/23449197b0c249d5940f29335e0658a3.png","type":0,"news_type":0,"thumbnails":["https://academy-public.coinmarketcap.com/srd-optimized-uploads/23449197b0c249d5940f29335e0658a3.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/6677ee9564861b00da5577f7/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4007","HUGE","MKR.USD.HKCC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fsdpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.4743},{"period":"1year","weight":-0.9072},{"period":"ytd","weight":-0.9023}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.104048},{"month":2,"riseRate":0.8,"avgChangeRate":0.112312},{"month":3,"riseRate":0,"avgChangeRate":-0.125472},{"month":4,"riseRate":0.2,"avgChangeRate":-0.100128},{"month":5,"riseRate":0,"avgChangeRate":-0.136163},{"month":6,"riseRate":0.4,"avgChangeRate":-0.061267},{"month":7,"riseRate":0.6,"avgChangeRate":-0.053277},{"month":8,"riseRate":0.6,"avgChangeRate":-0.015096},{"month":9,"riseRate":0,"avgChangeRate":-0.122196},{"month":10,"riseRate":0.25,"avgChangeRate":-0.168563},{"month":11,"riseRate":0.5,"avgChangeRate":0.094462},{"month":12,"riseRate":0,"avgChangeRate":-0.153828}],"exchange":"NASDAQ","name":"FSD Pharma Inc","nameEN":"FSD Pharma Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FSD Pharma Inc(HUGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest FSD Pharma Inc(HUGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"FSD Pharma Inc,HUGE,FSD Pharma Inc股票,FSD Pharma Inc股票老虎,FSD Pharma Inc股票老虎国际,FSD Pharma Inc行情,FSD Pharma Inc股票行情,FSD Pharma Inc股价,FSD Pharma Inc股市,FSD Pharma Inc股票价格,FSD Pharma Inc股票交易,FSD Pharma Inc股票购买,FSD Pharma Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FSD Pharma Inc(HUGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest FSD Pharma Inc(HUGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction